Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.99 USD | -2.44% | +6.12% | +15.65% |
Mar. 21 | Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | CLS Therapeutics Discloses its Views on Xenetic Biosciences | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.65% | 6.3M | |
-2.51% | 103B | |
+1.85% | 95.28B | |
+1.46% | 22.15B | |
-15.75% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.86% | 16.05B | |
+5.45% | 13.68B | |
+34.88% | 12.17B |
- Stock Market
- Equities
- XBIO Stock
- News Xenetic Biosciences, Inc.
- Xenetic Biosciences to Implement 1-for-10 Reverse Split